Information Provided By:
Fly News Breaks for November 21, 2019
SRCL
Nov 21, 2019 | 16:17 EDT
RBC Capital analyst Sean Dodge initiated coverage of Stericycle with an Outperform rating and $75 price target, stating that he sees "mounting evidence" that the company's turnaround plan is gaining traction, pointing to his checks that point to stable small-quantity medical waste business pricing. The stock's valuation is still attractive and shares "will continue grinding higher," the analyst contends.
News For SRCL From the Last 2 Days
There are no results for your query SRCL